These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24052511)

  • 1. Bigger, faster? Associations between hospital thrombolysis volume and speed of thrombolysis administration in acute ischemic stroke.
    Bray BD; Campbell J; Cloud GC; Hoffman A; Tyrrell PJ; Wolfe CD; Rudd AG;
    Stroke; 2013 Nov; 44(11):3129-35. PubMed ID: 24052511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital variation in thrombolysis times among patients with acute ischemic stroke: the contributions of door-to-imaging time and imaging-to-needle time.
    Sauser K; Levine DA; Nickles AV; Reeves MJ
    JAMA Neurol; 2014 Sep; 71(9):1155-61. PubMed ID: 25023407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
    Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke.
    Xian Y; Xu H; Lytle B; Blevins J; Peterson ED; Hernandez AF; Smith EE; Saver JL; Messé SR; Paulsen M; Suter RE; Reeves MJ; Jauch EC; Schwamm LH; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke.
    Man S; Xian Y; Holmes DN; Matsouaka RA; Saver JL; Smith EE; Bhatt DL; Schwamm LH; Fonarow GC
    JAMA; 2020 Jun; 323(21):2170-2184. PubMed ID: 32484532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.
    Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Wakerley B; Liang S; Rathakrishnan R; Chong VF; Ting EY; Sharma VK
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e590-6. PubMed ID: 23954601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can clinical audits be enhanced by pathway simulation and machine learning? An example from the acute stroke pathway.
    Allen M; Pearn K; Monks T; Bray BD; Everson R; Salmon A; James M; Stein K
    BMJ Open; 2019 Sep; 9(9):e028296. PubMed ID: 31530590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why are acute ischemic stroke patients not receiving IV tPA? Results from a national registry.
    Messé SR; Khatri P; Reeves MJ; Smith EE; Saver JL; Bhatt DL; Grau-Sepulveda MV; Cox M; Peterson ED; Fonarow GC; Schwamm LH
    Neurology; 2016 Oct; 87(15):1565-1574. PubMed ID: 27629092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolysis in young adults with stroke: Findings from Get With The Guidelines-Stroke.
    Dodds JA; Xian Y; Sheng S; Fonarow GC; Bhatt DL; Matsouaka R; Schwamm LH; Peterson ED; Smith EE
    Neurology; 2019 Jun; 92(24):e2784-e2792. PubMed ID: 31092622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
    Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
    JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke Thrombolysis in a Centralized and a Decentralized System (Helsinki and Telemedical Project for Integrative Stroke Care Network).
    Hubert GJ; Meretoja A; Audebert HJ; Tatlisumak T; Zeman F; Boy S; Haberl RL; Kaste M; Müller-Barna P
    Stroke; 2016 Dec; 47(12):2999-3004. PubMed ID: 27834751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group.
    Heuschmann PU; Berger K; Misselwitz B; Hermanek P; Leffmann C; Adelmann M; Buecker-Nott HJ; Rother J; Neundoerfer B; Kolominsky-Rabas PL; ;
    Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12663875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phased changes in strategies can reduce delay of intravenous thrombolysis administration to 15 min.
    Itabashi R; Shigehatake Y; Yazawa Y; Endo K; Saito T; Fukuma K; Furui E; Mori E
    J Neurol Sci; 2019 Aug; 403():59-64. PubMed ID: 31226551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very Early versus Delayed Rehabilitation for Acute Ischemic Stroke Patients with Intravenous Recombinant Tissue Plasminogen Activator: A Nationwide Retrospective Cohort Study.
    Momosaki R; Yasunaga H; Kakuda W; Matsui H; Fushimi K; Abo M
    Cerebrovasc Dis; 2016; 42(1-2):41-8. PubMed ID: 26986718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use and misuse of thrombolytic therapy within the Veterans Health Administration.
    Keyhani S; Arling G; Williams LS; Ross JS; Ordin DL; Myers J; Tyndall G; Vogel B; Bravata DM
    Med Care; 2012 Jan; 50(1):66-73. PubMed ID: 22182924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke.
    Lin CB; Cox M; Olson DM; Britz GW; Constable M; Fonarow GC; Schwamm L; Peterson ED; Shah BR
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26201547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-hospital delays to stroke thrombolysis: paradoxical effect of early arrival.
    Romano JG; Muller N; Merino JG; Forteza AM; Koch S; Rabinstein AA
    Neurol Res; 2007 Oct; 29(7):664-6. PubMed ID: 18173904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing in-hospital delay to 20 minutes in stroke thrombolysis.
    Meretoja A; Strbian D; Mustanoja S; Tatlisumak T; Lindsberg PJ; Kaste M
    Neurology; 2012 Jul; 79(4):306-13. PubMed ID: 22622858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of tissue plasminogen activator administration management between Telestroke Network hospitals and academic stroke centers: the Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany.
    Audebert HJ; Kukla C; Vatankhah B; Gotzler B; Schenkel J; Hofer S; Fürst A; Haberl RL
    Stroke; 2006 Jul; 37(7):1822-7. PubMed ID: 16763192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.